Long-Term Outcomes of COVID-19 in Hospitalized Type 2 Diabetes Mellitus Patients
With the onset of the coronavirus pandemic, it has become clear that patients with diabetes are at risk for more severe and fatal COVID-19. Type 2 diabetes mellitus (T2D) is a major risk factor for adverse COVID-19 outcomes. The goal of study was to assess the characteristics and outcomes of hospita...
Main Authors: | Zemfira Khamidullina, Diana Avzaletdinova, Diana Gareeva, Tatyana Morugova, Irina Lakman, Kristen Kopp, Lukas Fiedler, Lukas J. Motloch, Naufal Zagidullin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/2/467 |
Similar Items
-
Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia
by: Lukas J. Motloch, et al.
Published: (2022-06-01) -
Hyperlipidemia and mortality associated with diabetes mellitus co-existence in Chinese peritoneal dialysis patients
by: Xin Wei, et al.
Published: (2020-11-01) -
Mortality and Disability Due to Japanese Encephalitis in Elderly Adults: Evidence From an Adult Tertiary Care Center in West China
by: Weixi Xiong, et al.
Published: (2019-08-01) -
HEART RATE TURBULENCE AS A MORTALITY PREDICTOR IN LONG-TERM STUDY IN PATIENTS WITH CORONARY HEART DISEASE
by: D. Gareeva, et al.
Published: (2016-04-01) -
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
by: Lukas Fiedler, et al.
Published: (2023-05-01)